Chipmakers Are Caught in U.S.-China Crossfire
(Bloomberg Opinion) -- For years, it has been the best of times for computer-chip companies. Now, though, they're increasingly trapped in global political wars.Â
The latest example is the decision by a court in China to temporarily ban some sales there by Micron Technology Inc., the Idaho-based maker of memory chips essential to most smartphones. The court case centers on specialized technology that a rival company says Micron stole, although the tussle appears to be less about the law and mostly about the Chinese government's efforts to develop a homegrown computer-chip industry at any cost. Micron shares fell as much as 8 percent on the development.
The patent-infringement lawsuit was filed over Micron products used in computer graphics cards rather than over the company's cash-cow business in chips for higher-performance computers and phones. That means the financial impact on Micron from the sales ban will most likely be limited, although the political implications are profound.Â
Chip companies have been among the biggest industry winners as China has become an economic superpower, but now they find themselves caught in the crossfire between the U.S. and China, the two most important computer-chip markets.
In addition to Micron's legal fight in China, Qualcomm Inc. has been battling in China over regulatory inquiries and an acquisition that is held up by China's antitrust authority, perhaps in retaliation for the U.S. government's punishment of Chinese telecom equipment company ZTE. Chipmakers also appear to be on the losing end of U.S. tariffs that are trying to prevent, among other things, the kinds of Chinese technology theft that seems to have happened to Micron. A trade group has said U.S. policies could perversely make American chipmakers subject to the 25 percent tariffs intended for Chinese companies.Â
That's because chips that are considered imported from China may not be. Micron has disclosed that 51 percent of its revenue in its latest fiscal year came from sales to China. That figure is based on the places where Micron products were shipped, rather than the ultimate country where finished products turn up. For example, Micron might count as revenue from China its memory chips that wind up as components of smartphones assembled in Chinese factories, even if those phones are sold to customers in the U.S. or Europe.Â
Micron's patent fight is emblematic of the stew of factors that is making investors sour on chip companies. In addition to the tariff war with China and the fears of intellectual property disputes with Chinese companies, there is anxiety that the typical boom-and-bust cycle for certain chip industry categories is about to bust again. In part because of regulatory scrutiny motivated by global political factors, further consolidation will be tough in the industry, even in categories that can use it. All that angst has pushed an index of semiconductor companies to dip 10 percent since a record on March 12.Â
It's hardly the worst of time for chipmakers, though. Financial results have held up well for many companies, and they seem poised to benefit from technologies such as artificial intelligence and driverless cars that are likely to increase demand for computer chips. The outlook might be bright for the industry, but in the present the unpredictable actions of governments around the world have made chipmakers lose control of their own futures.
To contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.net
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.